STEM, SAPX, XDSL, WNBD, MCLN, COPI
Our Stocks to Watch today include StemCells Inc. (Nasdaq: STEM), Seven Arts Entertainment Inc. (Nasdaq: SAPX), mPhase Technologies Inc. (OTCBB: XDSL), Winning Brands Corp. (OTCBB: WNBD), MedClean Technologies Inc. (OTC: MCLN) and Compliance Systems Corp. (OTCBB: COPI).
STEMCELLS INCORPORATED (NASDAQ: STEM)
"Up 106.90% on Tuesday"
Detailed Quote: http://www.otcpicks.com/quotes/STEM.php
StemCells, Inc. is engaged in the research, development, and commercialization of cell-based therapeutics and tools for use in stem cell-based research and drug discovery. The Company's lead therapeutic product candidate, HuCNS-SC® cells (purified human neural stem cells), is currently in development as a potential treatment for a broad range of central nervous system disorders. In a Phase I clinical trial in Pelizaeus-Merzbacher disease (PMD), a fatal myelination disorder in children, the Company has shown preliminary evidence of progressive and durable donor-derived myelination in all four patients transplanted with HuCNS-SC cells. The Company is also conducting a Phase I/II clinical trial in chronic spinal cord injury in Switzerland and recently reported positive interim safety data for the first patient cohort. The Company has also initiated a Phase I/II clinical trial in dry age-related macular degeneration (AMD), and is pursuing preclinical studies in Alzheimer's disease. StemCells also markets stem cell research products, including media and reagents, under the SC Proven® brand.
July 17 - StemCells, Inc. Announces Its Human Neural Stem Cells Restore Memory in Models of Alzheimer's Disease
StemCells, Inc. (Nasdaq: STEM) announced preclinical data demonstrating that its proprietary human neural stem cells restored memory and enhanced synaptic function in two animal models relevant to Alzheimer's disease (AD). The data was presented today at the Alzheimer's Association International Conference 2012 in Vancouver, Canada.
The study results showed that transplanting the cells into a specific region of the brain, the hippocampus, statistically increased memory in two different animal models. The hippocampus is critically important to the control of memory and is severely impacted by the pathology of AD. Specifically, hippocampal synaptic density is reduced in AD and correlates with memory loss. The researchers observed increased synaptic density and improved memory post transplantation. Importantly, these results did not require reduction in beta amyloid or tau that accumulate in the brains of patients with AD and account for the pathological hallmarks of the disease.
The research was conducted in collaboration with a world-renowned leader in AD, Frank LaFerla, Ph.D., Director of the University of California, Irvine (UCI) Institute for Memory Impairments and Neurological Disorders (UCI MIND), and Chancellor's Professor, Neurobiology and Behavior in the School of Biological Sciences at UCI. Matthew Blurton-Jones, Ph.D., Assistant Professor, Neurobiology and Behavior at UCI, presented the study results.
"This is the first time human neural stem cells have been shown to have a significant effect on memory," said Dr. LaFerla. "While AD is a diffuse disorder, the data suggest that transplanting these cells into the hippocampus might well benefit patients with Alzheimer's. We believe the outcomes in these two animal models provide strong rationale to study this approach in the clinic and we wish to thank the California Institute of Regenerative Medicine for the support it has given this promising research."
Stephen Huhn, M.D., FACS, FAAP, Vice President and Head of the CNS Program at StemCells, added, "While reducing beta amyloid and tau burden is a major focus in AD research, our data is intriguing because we obtained improved memory without a reduction in either of these pathologies. AD is a complex and challenging disorder. The field would benefit from the pursuit of a diverse range of treatment approaches and our neural stem cells now appear to offer a unique and viable contribution in the battle against this devastating disease."
ABOUT ALZHEIMER'S DISEASE
Alzheimer's disease is a progressive, fatal neurodegenerative disorder that results in loss of memory and cognitive function. Today there is no cure or effective treatment option for patients afflicted by Alzheimer's disease. According to the Alzheimer's Association, approximately 5.4 million Americans have Alzheimer's disease, including nearly half of people aged 85 and older. The prevalence of Alzheimer's disease is expected to increase rapidly as a result of the country's aging population.
SEVEN ARTS ENTERTAINMENT INCORPORATED (NASDAQ: SAPX)
"Up 38.16% on Tuesday"
Detailed Quote: http://www.otcpicks.com/quotes/SAPX.php
Seven Arts Entertainment Inc. is the successor to Seven Arts Pictures Plc., which was founded in 2002 as an independent motion picture production and distribution company engaged in the development, acquisition, financing, production, and licensing of theatrical motion pictures for exhibition in domestic (i.e., the United States and Canada) and foreign theatrical markets, and for subsequent worldwide release in other forms of media, including home video and pay and free television.
July 12 - Seven Arts Entertainment Announces the US Theatrical Release of 'Drunkboat'
Seven Arts Entertainment Inc. (Nasdaq: SAPX) ("Seven Arts") announced the US theatrical release of "Drunkboat" (the "Film"). The film will be released on Friday, July 13th, exclusively through AMC Movie Theatres throughout major cities to include Chicago, Los Angeles, New York and Boston.
"Drunkboat" is the new tragi-comedy from playwright/director Bob Meyer, starring John Malkovich, John Goodman and Dana Delany. "Drunkboat" tells the story of Mort Gleason (Malkovich), who returns to the family home after a 25-year absence, where his sister (Delany) is raising her young son Abe. Abe is in the thrall of purchasing a sloop from an unscrupulous boat salesman (Goodman). Both powerful and touching, this film tells the story of a young man's dreams of sailing the world and an older man's reconciliation with his family.
Gabe Toro from IndieWire raves about the film, "It remains a pleasure to see, in Malkovich and Goodman, two canny pros at the top of their game".
"We are thrilled this picture will be released throughout the US and could not be more pleased to be working with AMC Theaters," said Peter Hoffman, CEO of Seven Arts. "This is a great movie that deserves to be shown to a wider audience."
Executive Producer Anthony Tomaska said, "Malkovich and Goodman are awesome together in this touching film."
MPHASE TECHNOLOGIES INCORPORATED (OTCBB: XDSL)
"Up 30.77% on Tuesday"
Detailed Quote: http://www.otcpicks.com/quotes/XDSL.php
mPhase Technologies is introducing a revolutionary Smart Surface technology enabled by breakthroughs in nanotechnology, MEMS processing and microfluidics. Our Smart Surface technology has potential applications within drug delivery systems, lab-on-a-chip analytic systems, self-cleaning systems, liquid and chemical sensor systems, and filtration systems. mPhase has pioneered its first Smart Surface enabled product, the mPhase Smart NanoBattery. In addition to the Smart Surface technology, mPhase recently introduced its first product, the mPower Emergency Illuminator, an award-winning product designed by Porsche Design Studio and sold via the mPower website at www.mpowertech.com.
July 17 - Stevens Institute of Technology and mPhase to Partner on Research and Business Opportunities
Stevens' Graphene-Based Inkjet Printing of Electrodes and Circuits to Be Explored
mPhase Technologies, Inc. (OTCBB: XDSL) and Stevens Institute of Technology have announced an official agreement to jointly pursue business opportunities with government and industry as well as research and development (R&D) projects.
Specifically, Stevens and mPhase will collaborate on the design and fabrication of an advanced battery technology utilizing intellectual property and know-how from both parties with the possibility of integrating and advancing mPhase's Smart NanoBattery Technology with Stevens' graphene-based inkjet printing method for printing electrodes and electronic circuits.
The parties also wish to explore the possibility of funding Stevens' research activities relative to graphene-based research projects to advance the inkjet printing of electronics utilizing advanced materials
"mPhase is excited to explore the possibilities of integrating Stevens' leading position in the inkjet printing of energy storage devices using graphene with mPhase's Smart NanoBattery Technology," said Ronald A. Durando, CEO of mPhase Technologies.
"Stevens looks forward to continuing its relationship with mPhase by pursuing this exciting opportunity," added Christos Christodoulatos, Associate Provost of Stevens, Office of Academic Entrepreneurship.
WINNING BRANDS CORPORATION (OTC: WNBD)
"Up 50.00% on Tuesday"
Detailed Quote: http://www.otcpicks.com/quotes/WNBD.php
Winning Brands Corporation manufactures Winning Colours® Stain Remover for consumer and commercial use as an eco-responsible alternative to traditional solvents. It is gaining popularity for its remarkable gentleness to skin and delicate surfaces, while still being a powerful and versatile stain remover. Main production takes place at the Grand Rapids, Michigan facility of Surefil LLC. Winning Brands' full product range includes a variety of advanced cleaning solutions, such as its non-toxic SMART™ Wet Cleaning liquid alternative to Perchloroethylene used in dry cleaning, KIND™ Laundry Products and CLEAN1™ — the first choice in outdoor cleaning. The company's mission is to replace hazardous chemicals in widespread use with safer alternatives. The initial focus is on cleaning products.
June 27 - Winning Brands Welcomes Cloverdale Paint Stores to its Retailer Network with Listing of 1000+™ Stain Remover
Winning Brands Corporation (OTCBB: WNBD), maker of 1000+™ Stain Remover, World's Most Versatile Cleaning Solution™, www.1000Plus.ca, is being listed by the paint manufacturer and retailer Cloverdale Paints www.cloverdalepaint.co, for sale in its stores. Cloverdale is a well-known and established coatings marketer in Western Canada, serving consumers and professionals.
Winning Brands CEO, Eric Lehner, comments: "Regional organizations are one of the three key tiers in distribution: local, regional and national. The decision by Cloverdale, with a strong presence in Western Canada, to carry 1000+ Stain Remover, is a positive development. Cloverdale is a technically sophisticated group and discerning on behalf of its customer base in choosing its product mix. Providing 1000+ Stain Remover to Cloverdale customers is an affirmation of the 1000+ brand and ensures that Cloverdale customers have the latest helpful products for their needs. Winning Brands will develop appropriate training materials with our distribution partner, Dynamic Paint Products, so that introduction of 1000+ Stain Remover to Cloverdale personnel goes smoothly. We expect to be in over 50 of these stores by the end of the summer."
MEDCLEAN TECHNOLOGIES INCORPORATED (OTCBB: MCLN)
"Up 100.00% on Tuesday"
Detailed Quote: http://www.otcpicks.com/quotes/MCLN.php
MedClean Technologies Inc., formerly Aduromed Industries Inc., provides solutions for managing medical waste onsite, including designing, selling, installing and servicing on site (in-situ) turnkey systems to treat regulated medical waste. The Company provides these systems to hospitals and other medical facilities as efficient, safe, cost effective and legally compliant solutions to incineration, off site hauling of untreated waste and other alternative treatment technologies and methodologies. MCLN's principal products are the MedClean series systems. Also effective January 2, 2009, the Company merged its former wholly owned subsidiary, Aduromed Corporation (Aduromed), with and into the Company.
No recent news for MedClean Technologies Inc. (OTC: MCLN).
COMPLIANCE SYSTEMS CORPORATION (OTCBB: COPI)
"Up 66.67% on Tuesday"
Detailed Quote: http://www.otcpicks.com/quotes/COPI.php
Compliance Systems Corporation, through its subsidiaries, provides compliance technologies, methodologies, and services to the teleservices industry. It primarily offers a compliance technology called the TeleBlock Call Blocking System, a patented process that automatically screens and blocks outbound calls against federal, state, and in-house do-not-call lists. The company also offers Regulatory Guide, an online and up-to-date compilation of state and federal telemarketing laws, as well as ongoing compliance auditing services. It is also developing Registration Guide, an online system designed to assist telemarketers to fill out state commercial registration forms. In addition, the company provides voice-over Internet protocol services. The company was incorporated in 2002 and is headquartered in Glen Cove, New York.
No recent news for Compliance Systems Corporation (OTCBB: COPI).